Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Oncology Today with Dr Neil Love
00:00
Timing, Polyclonality, and Clinical Implications
Panel debates early ctDNA detection, polyclonal ESR1 implications, and whether earlier switching yields better oral SERD efficacy.
Play episode from 54:08
Transcript
